UC San Diego researchers report successfully removing the nucleus from a type of ubiquitous cell, then using the genetically engineered cell as a unique cargo-carrier to deliver therapeutics precisely to diseased tissues.Researchers at University of California San Diego School of Medicine and Moores
Related Articles

News
Major Gift Focuses Efforts on a Rare, but Devastating, Genetic Eye Disease
December 15, 2021
sandiegobiotech
News
Comments Off on Major Gift Focuses Efforts on a Rare, but Devastating, Genetic Eye Disease
Nixon Foundation funds effort to study and treat macular dystrophy at Shiley Eye Institute. Currently, there are no effective treatments to slow or prevent genetic condition. Click here to view original post… […]

News
It Starts from Within
As Lucas Anthony Lima prepares to deliver a message of congratulations to his 7,000 peers as Commencement student speaker, he draws inspiration from the lessons he has instilled in his little brother. The most i… […]

News
Charting Shots
Many medical advances lay at least partial claim to greatest of all time, from older achievements like anesthesia (1846) and antibiotics (1928) to more modern triumphs like organ transplants (1954), stem cell th… […]